Skip to main content
Fig. 7 | Clinical Epigenetics

Fig. 7

From: Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance

Fig. 7

Schematic representation of CSCs epigenome as a target for cancer treatment. Various drugs including Aza-dC (Decitabine), SGI-110 or Zebularine, can reduce DNMT1 protein levels and global methylation. HDAC inhibitors (HDACI), including Mocetinostat, Entinostat and Belinostat, have demonstrated good effect toward inhibitation of HDAC. lncRNAs can be inhibit by GapmeRs or small molecule inhibitors which eventually will be disrupt

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us